Minulet (Ethinylestradiol, Gestodene)

Ethinylestradiol, the active ingredient in Minulet, is a combined oral contraceptive presented as a tablet for oral use. Together with gestodene, it works to prevent pregnancy by suppressing ovulation, thickening cervical mucus, and modifying the endometrial lining, providing reliable contraception for women of reproductive age through a well‑studied hormonal mechanism that has been used worldwide for decades.

GNH USA supplies Minulet as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures consistent quality and regulatory compliance across EU and global markets.

Minulet, a combined oral contraceptive, is indicated for hormonal contraception in women.

Prevention of pregnancy: provides reliable contraception for women of reproductive age. Regulation of menstrual cycle: helps achieve regular, predictable bleeding patterns. Management of dysmenorrhea: can reduce menstrual pain associated with ovulatory cycles.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: temporary swelling or sensitivity. - Spotting or irregular bleeding: breakthrough bleeding during the cycle.

Serious or Rare Side Effects: - Venous thromboembolism: blood clots in deep veins. - Stroke: cerebrovascular accident, especially in high‑risk individuals. - Severe allergic reaction: anaphylaxis or angioedema requiring immediate medical attention.

Before prescribing Minulet, clinicians should evaluate individual risk factors and contraindications. Assess thrombotic risk: avoid in women with a history of venous thromboembolism. Screen for cardiovascular disease: contraindicated in smokers over 35 years of age. Consider liver function: use with caution in hepatic impairment. Avoid during pregnancy: drug is contraindicated (Category X). Store at ambient temperature: keep below 25 °C, protect from moisture and light.

Minulet may have clinically significant interactions with several drug classes. Major Interactions (Avoid): - Antiepileptic enzyme inducers (e.g., carbamazepine, phenytoin): reduce contraceptive efficacy. - Rifampin or griseofulvin: may decrease hormone levels, risking breakthrough ovulation. - Certain antiretrovirals (protease inhibitors): unpredictable effects on hormone metabolism. Moderate Interactions (Monitor Closely): - St. John’s wort: may lower contraceptive effectiveness. - Selective serotonin reuptake inhibitors: may increase bleeding tendency. - Diuretics: may affect fluid balance and blood pressure.